Cingulate Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $96.67K, a 1.79% decline year-over-year.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2024-06-30 was $98.43K.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2024-03-31 was $24.02K.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $96.67K, a 69.69% decline from fiscal 2024.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $318.92K, a 4431.42% increase from fiscal 2023.
- Cingulate Inc. stock issued during period, value, restricted stock award, gross for fiscal 2023 was $7.04K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2025-12-31 | $96.67K 10-K · filed 2026-03-18 | |
| 2025-06-30 | $96.67K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $318.92K 10-K · filed 2026-03-18 | |
| 2024-06-30 | $98.43K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $24.02K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $7.04K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |